Medicine and Dentistry
Epileptic Seizure
100%
Neonates
68%
Pyridoxal 5 Phosphate
66%
Brain Ischemia
66%
Mesenchymal Stem Cell
66%
Intervention Study
66%
Neonatal Infant
66%
Bleeding
66%
Agents Acting on the Eye
66%
Magnetic Resonance Imaging
58%
Adverse Event
47%
High Risk Population
44%
Neurologic Disease
44%
Deterioration
33%
Fine-Needle Aspiration
22%
Hyperopia
22%
Vision Screening
22%
Eye Tracking
22%
Strabismus
22%
Functional Assessment
22%
Visual Impairment
22%
Nerve Cell Differentiation
22%
Pediatrics
22%
Patient Referral
22%
Food Supplement
19%
Human Study
19%
Neonatal Intensive Care Unit
19%
Pyridoxine
14%
Midline Shift
11%
Cerebral Hemorrhage
11%
Intracranial Hypertension
11%
Motor Development
11%
Minimally Invasive Procedure
11%
Clinician
11%
Spastic Diplegia
11%
Psychomotor Development
11%
Leukocyte
9%
Placebo-Controlled Study
9%
Vital Sign
9%
Therapy Effect
9%
Middle Cerebral Artery
9%
C Reactive Protein
9%
Procalcitonin
9%
Platelet
9%
Clinical Intervention
9%
Intranasal Drug Administration
9%
Pharmacology, Toxicology and Pharmaceutical Science
Intervention Study
66%
Pyridoxal 5 Phosphate
66%
Brain Ischemia
66%
Agents Acting on the Eye
66%
Adverse Event
47%
Neurologic Disease
44%
Hypermetropia
22%
Visual Impairment
22%
Strabismus
22%
Deterioration
22%
Human Study
19%
Pyridoxine
14%
C Reactive Protein
9%
Inflammation
9%
Procalcitonin
9%
Placebo-Controlled Study
9%
Therapeutic Effect
9%
Immunology and Microbiology
High Risk Population
66%
Mesenchymal Stem Cell
66%
Magnetic Resonance Imaging
55%
Nerve Cell Differentiation
33%
Eye Tracking
33%
Middle Cerebral Artery
11%
Platelet
11%
C-Reactive Protein
11%
Leukocyte Count
11%
Procalcitonin
11%